Report Scope & Overview:
Cancer Therapies Market size is expected to be worth around US$ 393.61 billion by 2032 from at US$ 164 billion in 2022, growing at a CAGR of 9.20% during the forecast period 2023 to 2032.
Executive Summary:
The global Cancer Therapies market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.
The report provides a thorough analysis of the current demand and supply environment of the global Cancer Therapies market, as well as the price trends in the market for the next few years. The leading global players in the market are profiled, including their revenue, market share, profit margin, major product portfolio and SWOT analysis. The report also provides an analysis of the supply chain from an industry perspective, including an introduction to the process chart, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
In addition, the report includes global and regional market size and forecasts, major product development trends, and typical downstream segment scenarios. The market drivers and inhibitors are analyzed in the context of these trends and scenarios. The report provides a comprehensive analysis of the market landscape, including competition analysis by price, revenue, sales, and market share by company, market rate, competitive situation landscape, and the latest trends, mergers, expansions, acquisitions, and market shares of top companies.
Global Cancer Therapies Market: By Company
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Bayer AG
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline PLC
• Johnson & Johnson
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
Global Cancer Therapies Market: By Type
• Immunological and Vaccine Approaches
• Antiproliferative Approaches
• Photodynamic Therapy
• Gene Therapy Approaches
• Cell Cycle and Apoptosis Approaches
Global Cancer Therapies Market: By Application
• Hospital Use
• Clinic Use
• Household
• Other
Global Cancer Therapies Market: Regional Analysis
The regional analysis of the global Cancer Therapies market provides insights into the market's performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Cancer Therapies market report are as follows:
North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Cancer Therapies in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.
Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Cancer Therapies in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.
Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Cancer Therapies in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.
Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.
South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Cancer Therapies in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
Reasons to Purchase Cancer Therapies Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Objectives of Cancer Therapies Market Study:
The objectives of Cancer Therapies market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Cancer Therapies market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
The global Cancer Therapies market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.
The report provides a thorough analysis of the current demand and supply environment of the global Cancer Therapies market, as well as the price trends in the market for the next few years. The leading global players in the market are profiled, including their revenue, market share, profit margin, major product portfolio and SWOT analysis. The report also provides an analysis of the supply chain from an industry perspective, including an introduction to the process chart, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
In addition, the report includes global and regional market size and forecasts, major product development trends, and typical downstream segment scenarios. The market drivers and inhibitors are analyzed in the context of these trends and scenarios. The report provides a comprehensive analysis of the market landscape, including competition analysis by price, revenue, sales, and market share by company, market rate, competitive situation landscape, and the latest trends, mergers, expansions, acquisitions, and market shares of top companies.
Cancer Therapies Market Key Trends
Immunotherapy Dominance: Continued dominance of immunotherapy, particularly immune checkpoint inhibitors and CAR-T cell therapies, as key components of cancer treatment strategies.
Precision Medicine and Biomarkers: Increasing emphasis on precision medicine, with a focus on identifying biomarkers to guide targeted therapies and enhance treatment efficacy.
Adoption of Targeted Therapies: Growing adoption of targeted therapies that aim to inhibit specific molecules or pathways involved in cancer growth, minimizing damage to healthy cells.
Cellular and Gene Therapies: Advancements in cellular and gene therapies, including the development of genetically modified T cells and other cell-based therapies for specific cancers.
Combination Therapies: Exploration and development of combination therapies to address the complexity and heterogeneity of cancer, combining different modalities for improved treatment outcomes.
Liquid Biopsy for Monitoring: Increasing use of liquid biopsy techniques for non-invasive monitoring of cancer progression, treatment response, and the detection of resistance mechanisms.
Artificial Intelligence (AI) in Drug Discovery: Integration of artificial intelligence and machine learning in drug discovery processes to identify potential drug candidates and optimize treatment regimens.
Market Segmentations:Global Cancer Therapies Market: By Company
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Bayer AG
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline PLC
• Johnson & Johnson
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
Global Cancer Therapies Market: By Type
• Immunological and Vaccine Approaches
• Antiproliferative Approaches
• Photodynamic Therapy
• Gene Therapy Approaches
• Cell Cycle and Apoptosis Approaches
Global Cancer Therapies Market: By Application
• Hospital Use
• Clinic Use
• Household
• Other
Global Cancer Therapies Market: Regional Analysis
The regional analysis of the global Cancer Therapies market provides insights into the market's performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Cancer Therapies market report are as follows:
North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Cancer Therapies in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.
Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Cancer Therapies in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.
Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Cancer Therapies in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.
Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.
South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Cancer Therapies in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
| Report Attribute/Metric | Details |
| Market Size 2022 | US$ 164 Billion |
| Market Size 2032 | US$ 393.61 Billion |
| Compound Annual Growth Rate (CAGR) | 9.20%(2023-2032) |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Forecast Units | Value (US$ Billion ) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • Immunological and Vaccine Approaches • Antiproliferative Approaches • Photodynamic Therapy • Gene Therapy Approaches • Cell Cycle and Apoptosis Approaches |
| By Application | • Hospital Use • Clinic Use • Household |
| Key Companies Profiled | • Amgen • AstraZeneca • Bristol-Myers Squibb • Bayer AG • F. Hoffmann-La Roche Ltd • GlaxoSmithKline PLC • Johnson & Johnson • Merck & Co. Inc. • Novartis AG • Pfizer Inc. |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase Cancer Therapies Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Objectives of Cancer Therapies Market Study:
The objectives of Cancer Therapies market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Cancer Therapies market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Frequently Asked Questions
TABLE OF CONTENT
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapies Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 Immunological and Vaccine Approaches
1.2.3 Antiproliferative Approaches
1.2.4 Photodynamic Therapy
1.2.5 Gene Therapy Approaches
1.2.6 Cell Cycle and Apoptosis Approaches
1.3 Market by Application
1.3.1 Global Cancer Therapies Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapies Market Perspective (2017-2032)
2.2 Cancer Therapies Growth Trends by Region
2.2.1 Global Cancer Therapies Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 Cancer Therapies Historic Market Size by Region (2017-2023)
2.2.3 Cancer Therapies Forecasted Market Size by Region (2023-2032)
2.3 Cancer Therapies Market Dynamics
2.3.1 Cancer Therapies Industry Trends
2.3.2 Cancer Therapies Market Drivers
2.3.3 Cancer Therapies Market Challenges
2.3.4 Cancer Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapies Players by Revenue
3.1.1 Global Top Cancer Therapies Players by Revenue (2017-2023)
3.1.2 Global Cancer Therapies Revenue Market Share by Players (2017-2023)
3.2 Global Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Therapies Revenue
3.4 Global Cancer Therapies Market Concentration Ratio
3.4.1 Global Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapies Revenue in 2022
3.5 Cancer Therapies Key Players Head office and Area Served
3.6 Key Players Cancer Therapies Product Solution and Service
3.7 Date of Enter into Cancer Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapies Breakdown Data by Type
4.1 Global Cancer Therapies Historic Market Size by Type (2017-2023)
4.2 Global Cancer Therapies Forecasted Market Size by Type (2023-2032)
5 Cancer Therapies Breakdown Data by Application
5.1 Global Cancer Therapies Historic Market Size by Application (2017-2023)
5.2 Global Cancer Therapies Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Cancer Therapies Market Size (2017-2032)
6.2 North America Cancer Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America Cancer Therapies Market Size by Country (2017-2023)
6.4 North America Cancer Therapies Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Therapies Market Size (2017-2032)
7.2 Europe Cancer Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe Cancer Therapies Market Size by Country (2017-2023)
7.4 Europe Cancer Therapies Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapies Market Size (2017-2032)
8.2 Asia-Pacific Cancer Therapies Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific Cancer Therapies Market Size by Region (2017-2023)
8.4 Asia-Pacific Cancer Therapies Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Therapies Market Size (2017-2032)
9.2 Latin America Cancer Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America Cancer Therapies Market Size by Country (2017-2023)
9.4 Latin America Cancer Therapies Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapies Market Size (2017-2032)
10.2 Middle East & Africa Cancer Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa Cancer Therapies Market Size by Country (2017-2023)
10.4 Middle East & Africa Cancer Therapies Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Therapies Introduction
11.1.4 Amgen Revenue in Cancer Therapies Business (2017-2023)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cancer Therapies Introduction
11.2.4 AstraZeneca Revenue in Cancer Therapies Business (2017-2023)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Cancer Therapies Introduction
11.3.4 Bristol-Myers Squibb Revenue in Cancer Therapies Business (2017-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Cancer Therapies Introduction
11.4.4 Bayer AG Revenue in Cancer Therapies Business (2017-2023)
11.4.5 Bayer AG Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Detail
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Cancer Therapies Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2017-2023)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 GlaxoSmithKline PLC
11.6.1 GlaxoSmithKline PLC Company Detail
11.6.2 GlaxoSmithKline PLC Business Overview
11.6.3 GlaxoSmithKline PLC Cancer Therapies Introduction
11.6.4 GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2017-2023)
11.6.5 GlaxoSmithKline PLC Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Cancer Therapies Introduction
11.7.4 Johnson & Johnson Revenue in Cancer Therapies Business (2017-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 Merck & Co. Inc.
11.8.1 Merck & Co. Inc. Company Detail
11.8.2 Merck & Co. Inc. Business Overview
11.8.3 Merck & Co. Inc. Cancer Therapies Introduction
11.8.4 Merck & Co. Inc. Revenue in Cancer Therapies Business (2017-2023)
11.8.5 Merck & Co. Inc. Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Detail
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Cancer Therapies Introduction
11.9.4 Novartis AG Revenue in Cancer Therapies Business (2017-2023)
11.9.5 Novartis AG Recent Development
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Detail
11.10.2 Pfizer Inc. Business Overview
11.10.3 Pfizer Inc. Cancer Therapies Introduction
11.10.4 Pfizer Inc. Revenue in Cancer Therapies Business (2017-2023)
11.10.5 Pfizer Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapies Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 Immunological and Vaccine Approaches
1.2.3 Antiproliferative Approaches
1.2.4 Photodynamic Therapy
1.2.5 Gene Therapy Approaches
1.2.6 Cell Cycle and Apoptosis Approaches
1.3 Market by Application
1.3.1 Global Cancer Therapies Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapies Market Perspective (2017-2032)
2.2 Cancer Therapies Growth Trends by Region
2.2.1 Global Cancer Therapies Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 Cancer Therapies Historic Market Size by Region (2017-2023)
2.2.3 Cancer Therapies Forecasted Market Size by Region (2023-2032)
2.3 Cancer Therapies Market Dynamics
2.3.1 Cancer Therapies Industry Trends
2.3.2 Cancer Therapies Market Drivers
2.3.3 Cancer Therapies Market Challenges
2.3.4 Cancer Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapies Players by Revenue
3.1.1 Global Top Cancer Therapies Players by Revenue (2017-2023)
3.1.2 Global Cancer Therapies Revenue Market Share by Players (2017-2023)
3.2 Global Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Therapies Revenue
3.4 Global Cancer Therapies Market Concentration Ratio
3.4.1 Global Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapies Revenue in 2022
3.5 Cancer Therapies Key Players Head office and Area Served
3.6 Key Players Cancer Therapies Product Solution and Service
3.7 Date of Enter into Cancer Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapies Breakdown Data by Type
4.1 Global Cancer Therapies Historic Market Size by Type (2017-2023)
4.2 Global Cancer Therapies Forecasted Market Size by Type (2023-2032)
5 Cancer Therapies Breakdown Data by Application
5.1 Global Cancer Therapies Historic Market Size by Application (2017-2023)
5.2 Global Cancer Therapies Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Cancer Therapies Market Size (2017-2032)
6.2 North America Cancer Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America Cancer Therapies Market Size by Country (2017-2023)
6.4 North America Cancer Therapies Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Therapies Market Size (2017-2032)
7.2 Europe Cancer Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe Cancer Therapies Market Size by Country (2017-2023)
7.4 Europe Cancer Therapies Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapies Market Size (2017-2032)
8.2 Asia-Pacific Cancer Therapies Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific Cancer Therapies Market Size by Region (2017-2023)
8.4 Asia-Pacific Cancer Therapies Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Therapies Market Size (2017-2032)
9.2 Latin America Cancer Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America Cancer Therapies Market Size by Country (2017-2023)
9.4 Latin America Cancer Therapies Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapies Market Size (2017-2032)
10.2 Middle East & Africa Cancer Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa Cancer Therapies Market Size by Country (2017-2023)
10.4 Middle East & Africa Cancer Therapies Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Therapies Introduction
11.1.4 Amgen Revenue in Cancer Therapies Business (2017-2023)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cancer Therapies Introduction
11.2.4 AstraZeneca Revenue in Cancer Therapies Business (2017-2023)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Cancer Therapies Introduction
11.3.4 Bristol-Myers Squibb Revenue in Cancer Therapies Business (2017-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Cancer Therapies Introduction
11.4.4 Bayer AG Revenue in Cancer Therapies Business (2017-2023)
11.4.5 Bayer AG Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Detail
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Cancer Therapies Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2017-2023)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 GlaxoSmithKline PLC
11.6.1 GlaxoSmithKline PLC Company Detail
11.6.2 GlaxoSmithKline PLC Business Overview
11.6.3 GlaxoSmithKline PLC Cancer Therapies Introduction
11.6.4 GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2017-2023)
11.6.5 GlaxoSmithKline PLC Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Cancer Therapies Introduction
11.7.4 Johnson & Johnson Revenue in Cancer Therapies Business (2017-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 Merck & Co. Inc.
11.8.1 Merck & Co. Inc. Company Detail
11.8.2 Merck & Co. Inc. Business Overview
11.8.3 Merck & Co. Inc. Cancer Therapies Introduction
11.8.4 Merck & Co. Inc. Revenue in Cancer Therapies Business (2017-2023)
11.8.5 Merck & Co. Inc. Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Detail
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Cancer Therapies Introduction
11.9.4 Novartis AG Revenue in Cancer Therapies Business (2017-2023)
11.9.5 Novartis AG Recent Development
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Detail
11.10.2 Pfizer Inc. Business Overview
11.10.3 Pfizer Inc. Cancer Therapies Introduction
11.10.4 Pfizer Inc. Revenue in Cancer Therapies Business (2017-2023)
11.10.5 Pfizer Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Amgen
AstraZeneca
Bristol-Myers Squibb
Bayer AG
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
AstraZeneca
Bristol-Myers Squibb
Bayer AG
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Delivery Microcatheter Market
Global Delivery Microcatheter Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Elastography System Market
Global Elastography System Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Orthopedic Robots Market
Global Orthopedic Robots Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Allergy Non-pharmacologic Therapy Market
Global Allergy Non-pharmacologic Therapy Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Dental Anaesthetic Needles Market
Global Dental Anaesthetic Needles Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast